CKD Bio Corp - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for CKD Bio Corp. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

CKD Bio Corp. The Company's principal activity is the providing of pharmaceutical products. The Company mainly provides antibiotic ingredients, consisting of potassium clavulanates, demethylchlortetracyclines (DMCTs) and rifampicins. It also develops immunosuppressive agents including cyclosporin and tacrolimus, and remedies for diabetes such as acarbose. The Company exports its products to China, the United States, Europe, Southeast Asia, Africa, South America and the Middle East. The Company operates a research laboratory concentrated on the production of therapeutic pharmaceuticals.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report